Healthcare Equipment and Supplies
Company Overview of B. Braun Medical Inc.
B. Braun Medical Inc. develops, manufactures, and markets infusion therapy and pain management products and services to the healthcare industry. The company offers clinical nutrition/compounding, closed system, drug preparation and delivery, interventional system, LDL apheresis therapy, ostomy care, regional anesthesia, renal therapy, and wound care products; infusion pumps, accessories, and services; IV sets, catheters, and accessories; irrigation/urology solutions and sets; IV solutions and drugs; and needles and syringes. Its products are used in the areas of anesthesia, emergency medicine, home infusion therapy, oncology and hematology, pharmacy, and surgery. B. Braun Medical Inc. was fo...
824 Twelfth Avenue
Bethlehem, PA 18018-3524
Founded in 1957
Key Executives for B. Braun Medical Inc.
Chairman and Chief Executive Officer
Chief Financial Officer, Senior Vice President and Director
Chief Operations Officer, Senior Vice President and Director
Director of Clinical and Technical Support
Chief Compliance Officer, Senior Vice President, General Counsel and Director
Compensation as of Fiscal Year 2016.
B. Braun Medical Inc. Key Developments
B. Braun Medical Inc. Launches New STEADYCare™ Extension Set with Wedge™ Catheter Stabilizer
Oct 3 16
B. Braun Medical Inc. announced that it has launched its new STEADYCare™ Extension Set with Wedge™ Catheter Stabilizer - developed to help improve stabilization and reduce catheter-related complications. STEADYCare was designed to minimize catheter movement in the vessel, maintain the catheter insertion angle, and reduce the patient connector's skin contact. Market data shows that approximately 90% of hospitalized patients require an IV catheter during their hospital stay, while 35% to 50% of catheters fail during therapy. Failures and unscheduled restarts are caused by catheter-related complications such as infection, phlebitis, hematoma, thrombosis and occlusion. Movement of the catheter may contribute to these complications. STEADYCare was recently unveiled at this year's Association for Vascular Access (AVA) Annual Scientific Meeting and the product is now available for sale.
B. Braun Medical Inc. to Exhibit Latest Advancements at Association for Vascular Access
Sep 13 16
B. Braun Medical Inc. will exhibit the latest advancements to its vascular access portfolio at this year's 30th Association for Vascular Access (AVA) Annual Scientific Meeting at Disney'sCoronado Springs Resort in Orlando, Sept. 16-19. B. Braun will unveil its new STEADYCare™ Extension Set with Wedge™ Catheter Stabilizer - developed to help improve stabilization and reduce catheter-related complications. It was designed to minimize catheter movement in the vessel, maintain the catheter insertion angle, and reduce the patient connector's skin contact. Visitors to booth #309 will be able to see and handle the new STEADYCare at AVA and the product will be available for sale in October. The company also will feature its new Ster-ASSIST™ Sterile Peripheral IV Catheter Insertion Kit, one of the first comprehensive sterile IV kits supporting ultrasound-guided PIV insertion. To promote best practices in sterile technique and clinician safety, while still providing convenience, B. Braun has packaged into a single kit all of the components needed to perform ultrasound-guided peripheral IV therapy procedures. At its booth #309, B. Braun will showcase the following products and have an ultrasound PIVC placement demonstration station where attendees will be able to practice insertion techniques with the use of ultrasound. Attendees also will be able to visit distinct areas within the booth to learn how they can improve peripheral IV access. Introcan Safety® IV Catheter - Designed with innovative, fully automatic passive-safety features to help eliminate accidental needlestick injury. From needle removal to disposal, clinicians are protected by a passive-safety device that is activated automatically -- no extra steps required and cannot be bypassed. Introcan Safety® 3 Closed IV Catheter - B. Braun's latest advancement, which takes the same preferred passive-safety engineered needlestick protection found in Introcan Safety and adds additional automatic protection from blood exposure. For safety and convenience, Introcan Safety 3's unique multi-access blood control septum is designed to minimize blood exposure during needle removal and each time the catheter hub is accessed. InVision-Plus® Neutral IV Connector - The most recent addition to the B. Braun needleless connector portfolio provides a 10-point standard of features and is offered through an exclusive U.S. distribution agreement with RyMed Technologies, LLC. B. Braun's portfolio of needleless connectors, including the CARESITE® Luer Access Device, offers a safe way to access IV lines through innovative features designed to help reduce catheter occlusions while protecting healthcare workers from accidental needlestick injuries.
B. Braun Medical Inc. to Launch Xevonta™
Sep 1 16
The Renal Therapies Division of B. Braun Medical Inc. announced that it will launch xevonta™, a next generation dialyzer for the U.S. market, after recently receiving 510(k) clearance. A dialyzer is a dialysis filter and is often referred to as an artificial kidney. Its function is to remove the wastes and excess fluid from the blood when a patient's kidneys can no longer perform the task. Available in September, xevonta will be offered in a broad range of sizes to accommodate different patient requirements. As a manufacturer and distributor of hemodialysis equipment and related disposables, including the Diacap @ Polysulfone® dialyzers and Medisystems' Streamline Bloodlines, the Renal Therapies Division of B. Braun is committed to the continued development of high quality products for hemodialysis and continuous renal replacement therapy supported by a team of clinical nurses, field service personnel, customer service and 24/7 technical assistance.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|